Published in Cancer Weekly, November 25th, 2003
German researchers were recently surprised when they "reproduced" a previously described phophatase inhibitor with known antitumor activity. The inhibitor had a completely different selectivity profile than that previously ascribed to it - possibly making the substance even more interesting.
Alois Furstner and Fabian Feyen of the Max-Planck-Institute for Carbon Research in Mulheim an der Ruhr, Germany, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.